| Offering Information |
| Expected Date | WITHDRAWN |
| Proposed Exchange/Ticker |
Nasdaq: ANSD |
| Security Type |
Common Stock |
| Lead Underwriter |
Vector Securities Intl |
| Days In Registration |
139 |
| Date Filed |
19-Feb-1999 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Manufacturing |
| Business Description |
Develop, manufacture, and wholesale leading edge technology disposable medical diagnostic products including drug testing products |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
2.5M |
| Chrm of Bd, President & CEO |
Stephen K. Schultheis |
| Number of Employees |
205 |
|
| Original Filing Information |
| US |
| Shares Filed |
2.5M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
375.0K |
| File Amount |
- |
| File Price Range |
$10.00 - $8.00 |
| File Mid Price |
$9.00 |
|
